| Q35831655 | (E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression |
| Q35312616 | Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism |
| Q40212333 | Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. |
| Q96954113 | An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling |
| Q35085783 | Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis |
| Q37191026 | Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells |
| Q60638027 | BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export |
| Q73200836 | Bad bones, grey hair, one mutation |
| Q33844646 | Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling |
| Q42473618 | Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice |
| Q38967844 | CD271 is an imperfect marker for melanoma initiating cells. |
| Q33882828 | Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization |
| Q34473579 | Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation |
| Q42220685 | Class II and IV HDACs function as inhibitors of osteoclast differentiation |
| Q44751346 | Comparative Transcriptome and DNA methylation analyses of the molecular mechanisms underlying skin color variations in Crucian carp (Carassius carassius L.). |
| Q33779245 | Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice |
| Q35433533 | Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF. |
| Q42160434 | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members |
| Q38347759 | Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts |
| Q39778248 | ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma |
| Q55068550 | Endothelin-1 protects human melanocytes from UV-induced DNA damage by activating JNK and p38 signalling pathways. |
| Q92090606 | Enhanced Activation of Rac1/Cdc42 and MITF Leads to Augmented Osteoclastogenesis in Autosomal Dominant Osteopetrosis Type II |
| Q52331557 | Enhancer variants reveal a conserved transcription factor network governed by PU.1 during osteoclast differentiation. |
| Q41842422 | Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors |
| Q24300916 | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 |
| Q47104550 | Ethyl linoleate inhibits α-MSH-induced melanogenesis through Akt/GSK3β/β-catenin signal pathway |
| Q52679967 | Evolutionary sequence comparison of the Mitf gene reveals novel conserved domains. |
| Q36331194 | Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant. |
| Q38541335 | Focus on the p38 MAPK signaling pathway in bone development and maintenance |
| Q36881589 | Generating quiescent stem cells |
| Q38906998 | Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation |
| Q34752049 | HDAC3 and HDAC7 have opposite effects on osteoclast differentiation |
| Q54452122 | HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors. |
| Q37833524 | Histochemistry and cell biology: the annual review 2010. |
| Q35848573 | Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation |
| Q47322777 | Immunohistochemical evaluation of microphthalmia-associated transcription factor expression in giant cell lesions |
| Q48006799 | Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation |
| Q90306391 | MITF and UV responses in skin: From pigmentation to addiction |
| Q35187734 | MITF in melanoma: mechanisms behind its expression and activity. |
| Q92254234 | MITF-the first 25 years |
| Q53453283 | Malignant Melanoma With Osteoclast-Like Differentiation. |
| Q27024061 | Melanoma: from mutations to medicine |
| Q57307987 | Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice |
| Q53656611 | Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. |
| Q38394400 | Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. |
| Q35071659 | Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors |
| Q33848784 | Mitf induction by RANKL is critical for osteoclastogenesis |
| Q34257775 | Mitf regulates osteoclastogenesis by modulating NFATc1 activity |
| Q26851553 | Modulation of osteoclast differentiation and bone resorption by Rho GTPases |
| Q37951952 | Molecular Network Associated with MITF in Skin Melanoma Development and Progression |
| Q37169549 | Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis |
| Q35157702 | Molecular mechanisms underlying osteoclast formation and activation |
| Q50701558 | OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption. |
| Q35188522 | Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKL |
| Q92022414 | Osteoblasts contribute to a protective niche that supports melanoma cell proliferation and survival |
| Q29547556 | Osteoclast differentiation and activation |
| Q46960866 | Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. |
| Q37036135 | Osteoclasts-Key Players in Skeletal Health and Disease |
| Q60928140 | Propofol promotes osteoclastic bone resorption by increasing DC-STAMP expression |
| Q38878942 | Proteomic approaches to study osteoclast biology |
| Q47256563 | RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. |
| Q33820660 | Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor |
| Q64069924 | Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases |
| Q37868994 | Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors |
| Q57056148 | Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology |
| Q52352323 | Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. |
| Q35577020 | Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations |
| Q35126799 | Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts |
| Q26766637 | Signaling Pathways in Osteoclast Differentiation |
| Q36082866 | Signaling networks that control the lineage commitment and differentiation of bone cells |
| Q34616432 | Stepping up melanocytes to the challenge of UV exposure |
| Q39957832 | Stimulation of macrophage TNFalpha production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-kappaB pathways but is independent of p38 and JNK. |
| Q34166675 | Strength of TRAF6 signalling determines osteoclastogenesis |
| Q42370407 | Stress-induced haematopoietic stem cell proliferation: new roles for p38α and purine metabolism. |
| Q33847268 | Subcellular localization of Mitf in monocytic cells |
| Q34312986 | Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner |
| Q28118825 | Sumoylation of MITF and its related family members TFE3 and TFEB |
| Q33851600 | TGF-β inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways |
| Q83061700 | Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis |
| Q35740987 | The 19S proteasomal lid subunit POH1 enhances the transcriptional activation by Mitf in osteoclasts |
| Q51810609 | The Importance of 11α-OH, 15-oxo, and 16-en Moieties of 11α-Hydroxy-15-oxo-kaur-16-en-19-oic Acid in Its Inhibitory Activity on Melanogenesis. |
| Q30009200 | The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival |
| Q28274046 | The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor |
| Q42182548 | The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis |
| Q52019222 | The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. |
| Q37428651 | The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF). |
| Q38048776 | The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look |
| Q28251189 | The regulation of cathepsin K gene expression |
| Q37397466 | The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue |
| Q37931402 | The role of mitogen- and stress-activated protein kinase pathways in melanoma |
| Q38238861 | The roles of microphthalmia-associated transcription factor and pigmentation in melanoma |
| Q35834767 | The transcription network regulating melanocyte development and melanoma |
| Q83324534 | Transcriptional activation of tyrosinase gene by human placental sphingolipid |
| Q28679148 | Transcriptional regulation by the MAP kinase signaling cascades |
| Q100465050 | Transcriptional regulators and alterations that drive melanoma initiation and progression |
| Q28592680 | UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1) |
| Q28216853 | Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway |
| Q33344607 | Vitiligo puzzle: the pieces fall in place |
| Q33876438 | [6]-Shogaol inhibits α-MSH-induced melanogenesis through the acceleration of ERK and PI3K/Akt-mediated MITF degradation |
| Q21136315 | miR-148 regulates Mitf in melanoma cells |
| Q44536102 | p-Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. |